Alfasigma bets on rheumatology growth as filgotinib advances in axSpA
Source: news.google.com
Published: Jun 29, 2026 15:22
Source: news.google.com
Published: Jun 29, 2026 15:22
Related Stories
NeuroSense’s ALS drug cuts key biomarker in Phase IIb trial Yahoo
#Clinical TrialsCambridge biotech Alopexx files to go public with $30M IPO The Business Journals
#Biotech HeadlinesNew ALS treatment enters human testing in global program ALS News Today
#Clinical TrialsClinical trials are reshaping health outcomes for Colorado residents The Business Journals
#Clinical TrialsBiotech Bigwigs ABBV, JNJ, BIIB & LLY Hit New 52-Week Highs Yahoo Finance Singapore
#Biotech HeadlinesWhen Back Pain Won’t Quit: A Large Clinical Trial Points to the Power of Self-Management UPMC
#Clinical TrialsAdd Shortcut
Open this site faster like an app from your phone home screen.